Evidence map›Paper›PMID 20946925›Full record

ReviewAdvanced drug delivery reviews2010

Targeted renal therapies through microbubbles and ultrasound.

Leo E Deelman, Anne-Emilie Declèves, Joshua J Rychak, Kumar Sharma

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Novel Drug Delivery Technologies and Targets for Renal Disease.Hypertension (Dallas, Tex. : 1979) · 2022
    Review
  5. Review
  6. Review
  7. The future of marginal kidney repair in the context of normothermic machine perfusion.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2018
    Review
  8. Article
  9. New Ultrasound Techniques Promise Further Advances in AKI and CKD.Journal of the American Society of Nephrology : JASN · 2017
    Review
  10. Article
  11. Targeting Anti-TGF-Journal of the American Society of Nephrology : JASN · 2017
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Leveraging the power of ultrasound for therapeutic design and optimization.Journal of controlled release : official journal of the Controlled Release Society · 2011
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leo E DeelmanDepartment of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Netherlands. L.E.Deelman@med.umcg.nl
Anne-Emilie Declèves
Joshua J Rychak
Kumar Sharma

Funding

TGF-b signaling in diabetic kidney diseaseR01DK053867 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHARMA, KUMAR · 1999 to 2009
$2.5M
Ultrasound-triggered delivery of siRNA as treatment for diabetic kidney diseaseR44DK083142 · NIDDK · TARGESON, INC. · PI RYCHAK, JOSHUA J. · 2011 to 2012
$1.3M
Ultrasound mediated targeted therapy for kidney diseaseR43DK083142 · NIDDK · TARGESON, LLC · PI RYCHAK, JOSHUA J. · 2009 to 2010
$198k
NIDDK NIH HHS R01 DK053867NIDDK NIH HHS R01DK053867NIDDK NIH HHS R41DK083142-01NIDDK NIH HHS R43 DK083142NIDDK NIH HHS R44 DK083142
6 · The paper itself

Abstract

Microbubbles and ultrasound enhance the cellular uptake of drugs (including gene constructs) into the kidney. Microbubble induced modifications to the size selectivity of the filtration capacity of the kidney may enable drugs to enter previously inaccessible compartments of the kidney. So far, negative renal side-effects such as capillary bleeding have been reported only in rats, with no apparent damage in larger models such as pigs and rabbits. Although local delivery is accomplished by applying ultrasound only to the target area, efficient delivery using conventional microbubbles has depended on the combined injection of both drugs and microbubbles directly into the renal artery. Conjugation of antibodies to the shell of microbubbles allows for the specific accumulation of microbubbles in the target tissue after intravenous injection. This exciting approach opens new possibilities for both drug delivery and diagnostic ultrasound imaging in the kidney.

Indexed as

Drug Delivery SystemsMicrobubblesAnimalsContrast MediaGenetic TherapyGene Transfer TechniquesHumansInjections, IntravenousKidneyKidney DiseasesRabbitsRatsSwineUltrasonicsContrast Media

Identifiers

PMID20946925
PMCPMC2992851

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.